XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access
via the World Wide Web to its presentation at the Jefferies 2015 Global
Healthcare Conference. The live presentation will occur at 7:00 a.m.
Pacific Time (10:00 a.m. Eastern Time) on Thursday, June 4, 2015. A
replay of the presentation will also be available.
To access the live presentation via the Web, please go to www.XenoPort.com.
Please connect to the website at least 15 minutes prior to the live
presentation to ensure adequate time for any software downloads that may
be necessary to listen to the Webcast.
A replay of the Webcast can be accessed for a minimum of one month and
will be available approximately 24 hours after the live presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on developing and
commercializing a portfolio of internally discovered product candidates
for the potential treatment of neurological disorders. XenoPort is
currently commercializing HORIZANT® (gabapentin enacarbil)
Extended-Release Tablets in the United States and developing its novel
fumaric acid ester product candidate, XP23829, as a potential treatment
for patients with moderate-to-severe chronic plaque-type psoriasis and
potentially for relapsing forms of multiple sclerosis. REGNITE®
(gabapentin enacarbil) Extended-Release Tablets is being marketed in
Japan by Astellas Pharma Inc. XenoPort has entered into a clinical trial
agreement with the National Institute on Alcohol Abuse and Alcoholism
(NIAAA) under which the NIAAA plans to conduct a clinical trial
evaluating gabapentin enacarbil as a potential treatment for alcohol use
disorder, and XenoPort has granted exclusive world-wide rights for the
development and commercialization of its clinical-stage oral product
candidate, arbaclofen placarbil, to Indivior PLC for all indications.
XenoPort's pipeline of product candidates also includes a potential
treatment for patients with idiopathic Parkinson's disease.
To learn more about XenoPort, please visit the website at www.XenoPort.com.
XNPT2G
View source version on businesswire.com: http://www.businesswire.com/news/home/20150518005471/en/
Copyright Business Wire 2015